Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus glucocorticoids for adult IgA nephropathy
ChiCTR-IPR-15006760Phase 4Not yet recruiting
- Sponsor
- San Antonio Kidney Disease Center
- Start
- Aug 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in IgA nephropathy (IgAN) (2 arms), sponsored by San Antonio Kidney Disease Center. Primary endpoint: 24-hour urinary protein quantitation. Planned start Aug 2015; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-IPR-15006760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006760.